Is Automated Insulin Delivery System Therapy Safe and Effectıve in Children Under 7 Years Old?
The absence of significantly higher levels of hypoglycemia compared to other groups at any time point, along with a significant decrease in TAR across all time points, a significant increase in TIR at the 3<sup>rd</sup> and 12<sup>th</sup> months, and a significant decrease in HbA1c and CV suggests that the MiniMed™ 780G system is both safe and effective for children under seven years old.
Authors
- Günay Demir (ORCID: https://orcid.org/0000-0003-1468-1647)
- Şükran Darcan (ORCID: https://orcid.org/0000-0002-1330-6397)
- Yasemin Atik Altınok (ORCID: https://orcid.org/0000-0001-5851-1012)
- Samim Özen (ORCID: https://orcid.org/0000-0001-7037-2713)
- Damla Gökşen (ORCID: https://orcid.org/0000-0001-6108-0591)
- Deniz Özalp Kızılay (ORCID: https://orcid.org/0000-0003-4529-4404)
- N. Uslu
Institutions
- Ege University (TR)
Publication Details
- Journal
- Journal of Clinical Research in Pediatric Endocrinology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.4274/jcrpe.galenos.2024.2024-11-2
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.36